Profil
Mr. Nedal Safwat is on the Board of Directors at Gradientech AB. Mr. Safwat was previously employed as a VP & Head-Molecular Diagnostics North America by QIAGEN NV and a Chief Strategy Officer by Accelerate Diagnostics, Inc. He received his undergraduate degree from North Carolina State University and a doctorate degree from North Carolina State University.
Postes actifs de Nedal Safwat
| Sociétés | Poste | Début |
|---|---|---|
Gradientech AB
Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services | Directeur/Membre du Conseil | 09/05/2023 |
Anciens postes connus de Nedal Safwat
| Sociétés | Poste | Fin |
|---|---|---|
| QIAGEN N.V. | Corporate Officer/Principal | 01/12/2024 |
| ACCELERATE DIAGNOSTICS, INC. | Corporate Officer/Principal | - |
Formation de Nedal Safwat
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gradientech AB
Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services | Health Technology |
















